Evidence map›Paper›PMID 40928575›Full record

ArticleAnnals of surgical oncology2025

Development and Validation of an Individualized Prediction Model for Postoperative Late Recurrence After Hepatectomy for Hepatocellular Carcinoma (POLAR-HCC): A Multicenter Study.

Xin-Fei Xu, Han Wu, Li-Hui Gu, Yu-Ze Zhao, Ya-Hao Zhou, Ting-Hao Chen, Hong-Wei Guo, Zhong Chen, Kong-Ying Lin, Wei-Min Gu and 11 more

Abstract readMulticenter StudyValidation Study
PubMed Publisher
In one paragraph

Article in Annals of surgical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Xin-Fei XuDepartment of Hepatobiliary Surgery, Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Shanghai, China.
Han WuDepartment of Hepatobiliary Surgery, Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Shanghai, China.
Li-Hui GuDepartment of Hepatobiliary Surgery, Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Shanghai, China.
Yu-Ze ZhaoDepartment of Hepatobiliary Surgery, Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Shanghai, China.
Ya-Hao ZhouDepartment of Hepatobiliary Surgery, Pu'er People's Hospital, Yunnan, China.
Ting-Hao ChenDepartment of General Surgery, Ziyang First People's Hospital, Sichuan, China.
Hong-Wei GuoThe Second Department of General Surgery, The Second People's Hospital of Changzhi, Changzhi, China.
Zhong ChenDepartment of Hepatobiliary Surgery, Affiliated Hospital of Nantong University, Nantong, China.
Kong-Ying LinDepartment of Hepatobiliary Surgery, Mengchao Hepatobiliary Hospital, Fujian Medical University, Fuzhou, China.
Wei-Min GuThe First Department of General Surgery, The Fourth Hospital of Harbin, Heilongjiang, China.
Zi-Xuan WangDepartment of Hepatobiliary and Pancreatic Surgery, General Surgery Center, First Hospital of Jilin University, Changchun, China.
Hong WangDepartment of General Surgery, Liuyang People's Hospital, Hunan, China.
Xian-Ming WangDepartment of General Surgery, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Jinan, China.
Yong-Kang DiaoDepartment of Hepatobiliary Surgery, Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Shanghai, China.
Chao LiDepartment of Hepatobiliary Surgery, Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Shanghai, China.
Lan-Qing YaoDepartment of Hepatobiliary Surgery, Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Shanghai, China.
Ming-Da WangDepartment of Hepatobiliary Surgery, Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Shanghai, China.
Timothy M PawlikDepartment of Surgery, Ohio State University, Wexner Medical Center, Columbus, OH, USA.
Feng ShenDepartment of Hepatobiliary Surgery, Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Shanghai, China.
Tian YangDepartment of Hepatobiliary Surgery, Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Shanghai, China. yangtianehbh@smmu.edu.cn.
Eastern HepatoBiliary Alliance (EHBA) group

Funding

Dawn Project Foundation of Shanghai 21SG36Natural Science Foundation of Shanghai 22ZR1477900Shanghai Health and Hygiene Discipline Leader Project 2022XD001Shanghai Outstanding Academic Leader Program 23XD1424900Star Cultivation Project of Science and Technology Innovation Action Plan in Shanghai 2024 24YF2758500the National Natural Science Foundation of China 82273074the National Natural Science Foundation of China 82372813the National Natural Science Foundation of China 82425049the National Science and Technology Major Project of the Ministry of Science and Technology of China 2024ZD0520500the National Science and Technology Major Project of the Ministry of Science and Technology of China 2024ZD0520506
6 · The paper itself

Abstract

backgroundPostoperative late recurrence (POLAR) after 2 years from the date of surgical resection of hepatocellular carcinoma (HCC) represents a unique surveillance and management challenge. Despite identified risk factors, individualized prediction tools to guide personalized surveillance strategies for recurrence remain scarce. The current study sought to develop a predictive model for late recurrence among patients undergoing HCC resection.

methodsThis multicenter study analyzed HCC patients who underwent resection across 10 Chinese hepatobiliary centers and remained recurrence-free at 2 years after hepatectomy. Patients were randomly assigned to development and validation cohorts (2:1 ratio). Independent predictors identified through multivariate Cox regression analysis were integrated into a nomogram and web-based calculator.

resultsAmong 849 recurrence-free patients at 2 years after hepatectomy for HCC, seven independent predictors of POLAR were identified: male (hazard ratio [HR] 1.37, p = 0.04), cirrhosis (HR 1.42, p = 0.008), multiple tumors (HR 1.56, p = 0.006), satellite nodules (HR 1.59, p = 0.004), large tumor size (HR 1.49, p = 0.009), macrovascular invasion (HR 4.63, p < 0.001), and microvascular invasion (HR 1.69, p = 0.001). The POLAR-HCC nomogram-based calculator demonstrated robust performance in both the development (area under the curve [AUC] 0.660) and validation (AUC 0.626) cohorts. Using the optimal cut-off value of 1.93, patients were accurately stratified into high- and low-risk groups with different risks of POLAR (p < 0.001).

conclusionsThe POLAR-HCC online calculator enables risk stratification for POLAR after HCC resection. By integrating tumor characteristics and host factors, this prediction tool identified high-risk patients who may benefit from intensified recurrence surveillance, potentially improving long-term survival through earlier detection of POLAR. The model represents an important step toward personalized surveillance strategies among patients undergoing HCC resection.

Indexed as

Carcinoma, HepatocellularHepatectomyLiver NeoplasmsNeoplasm Recurrence, LocalNomogramsAgedFemaleFollow-Up StudiesHumansMaleMiddle AgedNeoplasm InvasivenessPrognosisRisk FactorsSurvival RateHepatocellular carcinomaLate recurrenceNomogramOnline calculatorSurgery

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.